We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Benefits of Bariatric Surgery Outweigh Risks in Obese Adults

By HospiMedica International staff writers
Posted on 29 Mar 2011
Bariatric surgery can result in long-term weight loss and significant reductions in cardiac and other risk factors for some severely obese adults, according to a new scientific statement from the American Heart Association (AHA; Dallas, TX, USA). More...


The AHA statement is a consensus document that provides expert perspective based on the review of recent scientific literature. The statement-writing committee found that, when indicated, bariatric surgery leads to significant weight loss and improvements in the health consequences of being overweight, such as diabetes, high cholesterol, liver disease, high blood pressure, obstructive sleep apnea (OSA) and cardiovascular dysfunction. Recent studies have suggested that bariatric surgery prolongs life in the severely obese, although there is little data on bariatric surgery in certain populations, such as adolescents, even though these patients are already undergoing the procedure at many centers.

However, the surgery has historically carried an operative mortality risk between 0.1% and 2.0%, and complications include pulmonary embolus, anastomotic leaks, bleeding, anastomotic stricture, anastomotic ulcers, hernias, band slippage, and behavioral maladaptation. Patients must make lifelong behavior changes, such as supplement use, and follow up with the surgical team. The authors find that the value of psychological evaluations and profiles in bariatric surgery cases is uncertain, and suggest that psychological evaluations should assess the behavioral and environmental factors that may have contributed to a patient's obesity, as well as the potential impact on a patient's ability to make the dietary and behavioral changes needed to achieve the best results from surgery.

The scientific statement further suggests some other issues must be researched, such as the impact of bariatric surgery on factors that may regulate appetite such as gastrointestinal peptides, ghrelin, cholecystokinin, and many other neuroendocrine factors that may differ, depending on the surgery approach used. Available data also suggest that procedures performed in centers of excellence do not necessarily yield better outcomes than bariatric procedures performed at lower-volume centers, indicating that the importance of procedure volume and operator expertise needs further study. The statement was published in the March 14, 2011, issue of Circulation.

"Bariatric procedures are generally safe; however, this is not a benign surgery,” said lead author Paul Poirier, MD, PhD, of Laval University Hospital (Quebec City, Canada). "At the moment, bariatric surgery should be reserved for patients who can undergo surgery safely, have severe obesity and have failed attempts at medical therapy.”

Related Links:
American Heart Association
Laval University Hospital




Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Hemostatic Agent
HEMOBLAST Bellows
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.